期刊文献+

The latest advances of experimental research on targeted gene therapy for prostate cancer 被引量:1

前列腺癌靶向基因治疗实验研究的最新进展(英文)
暂未订购
导出
摘要 The absence of effective therapies for castration-resistant prostate cancer(CRPC) establishes the need to develop novel therapeutic modality, such as targeted gene therapy, which is ideal for the treatment of CRPC. But its application has been limited due to lack of favorable gene vector and the reduction of "bystander effect". Consequently, scientists all over the world focus their main experimental research on the following four aspects: targeted gene, vector, transfer means and comprehensive therapy. In this paper, we reviewed the latest advances of experimental research on targeted gene therapy for prostate cancer.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第11期546-550,共5页 中德临床肿瘤学杂志(英文版)
关键词 cancer PROSTATE targeted gene THERAPY experimental research 基因治疗 前列腺癌 实验 基因载体 旁观者效应 治疗方式 综合治疗 传送装置
  • 相关文献

参考文献23

  • 1Chen Y, Wang G, Kong D, et al. In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine den?drimers for PC-3 cell line. World J Surg Oncol, 2012, 10: 3.
  • 2Xie X, Guo J, Kong Y, et al. Targeted expression of E. coli purine nucleoside phosphorylase and Fludara for prostate cancer therapy. J Gene Med, 2011, 13: 680-691.
  • 3Wang H, Zhang C, Rorick A, et al. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability. Can?cer Res, 2011,71: 4866-4876.
  • 4Greiner M, Kreutzer B, Jung V, et al. Silencing of the SEC62 gene in?hibits migratory and invasive potential of various tumor cells. Int J Cancer, 2011, 128: 2284-2295.
  • 5Yu C, Wu G, Dang N, et al. Inhibition of N-myc downstream-reg?ulated gene 2 in prostatic carcinoma. Cancer Bioi Ther, 2011, 12: 304-313.
  • 6Forootan SS, Bao ZZ, Forootan FS, et al. Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for pros?tate cancer in mouse xenografts. Int J Oncol, 2010, 36: 69-76.
  • 7Fan JK, Wei N, Ding M, et al. Targeting gene-viro therapy for prostate cancer by DD3-driven oncolytic virus-harboring interleukin-24 gene. Int J Cancer, 2010,127: 707-717.
  • 8Shao L, Tekedereli I, Wang J, et al. Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors. Clin Can?cer Res, 2012, 18: 6648-6657.
  • 9Magnusson MK, Kraaij R, Leadley RM, et al. A transductionally retar?geted adenoviral vector for virotherapy of Her2/neu-expressing pros?tate cancer. Hum Gene Ther, 2012, 23: 70-82.
  • 10Luo WY, Shih YS, Lo WH, et al. Baculovirus vectors for antiangio?genesis-based cancer gene therapy. Cancer Gene Ther, 2011, 18: 637-645.

同被引文献13

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部